Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-09

FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Clozapine submitted by Aurobindo Pharma Limited, enabling the marketing of a generic Clozapine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)